When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

HIV infection in pregnancy

Última revisão: 18 Aug 2025
Última atualização: 05 Feb 2025

Resumo

Definição

病史和体格检查

关键诊断因素

  • increased risk of maternal HIV infection
  • increased risk of perinatal HIV transmission
完整详情

其他诊断因素

  • oral candidiasis
  • increasing dyspnea
  • weight loss
  • fever
  • malaise
  • lymphadenopathy
  • maculopapular blanching rash
完整详情

危险因素

  • needle-sharing with injection drug use
  • unprotected receptive penile-vaginal intercourse
  • unprotected receptive anal intercourse
  • percutaneous needle stick
  • sexually transmitted infections (STIs) and bacterial vaginosis
  • high maternal viral load (perinatal transmission)
  • absence of prenatal maternal antiretroviral therapy (perinatal transmission)
  • breast-feeding in mothers without viral suppression (perinatal transmission)
  • violence against women and girls
  • receptive oral intercourse
  • insertive oral intercourse
  • multiple sexual partners
  • low maternal CD4 count (perinatal transmission)
完整详情

诊断性检查

首要检查

  • maternal HIV-1/HIV-2 antigen/antibody enzyme-linked immunosorbent assay (ELISA)
  • maternal HIV-1/HIV-2 antibody differentiation immunoassay
  • neonatal HIV DNA or RNA polymerase chain reaction (PCR)
完整详情

需考虑的检查

  • HIV-1 western blot
  • HIV-1 indirect immunofluorescence assay (IFA)
  • HIV-1 nucleic acid test (NAT)
  • CD4 count
  • plasma HIV RNA levels (viral load)
  • renal function tests
  • liver function tests (LFTs)
  • drug resistance tests
  • complete blood count
  • glucose screening
  • fetal ultrasound
  • tests for coinfections
完整详情

治疗流程

急症处理

HIV-1-infected pregnant women: <38 weeks not in labor (regardless of HIV RNA level)

HIV-1-infected pregnant women with HIV-1 RNA levels >1000 copies/mL: at 38 weeks or in labor

HIV-1-infected pregnant women with HIV-1 RNA levels ≤1000 copies/mL: at 38 weeks or in labor

infants born to HIV-infected mothers

撰稿人

作者

Rachel K. Scott, MD, MPH, FACOG

Associate Professor of Obstetrics and Gynecology

Georgetown University School of Medicine

Scientific Director of Women’s Health Research

MedStar Health Research Institute

Associate Chair for Research

MedStar Washington Hospital Center Department of Women’s and Infants’ Services

Washington

DC

利益声明

RKS declares that she has participated in an advisory meeting for ViiV Healthcare and has received research funding from ViiV, managed by MedStar Health Institute.

鸣谢

Dr Rachel K. Scott would like to gratefully acknowledge Dr Isaac Delke, Dr Christina Bailey, and Dr Mettassebia Kano, the previous contributors to this topic.

利益声明

ID, CB, and MK declare that they have no competing interests.

同行评议者

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

利益声明

AS declares that she has no competing interests.

Graham P. Taylor, MBChB, FRCP, FHEA

Reader in Communicable Diseases

Faculty of Medicine

Imperial College

London

UK

利益声明

GPT has been reimbursed by various pharmaceutical companies for attending conferences, lecturing, and consulting, and has been chief investigator of investigator-initiated industry-funded research on HIV and pregnancy.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. Jan 2024 [internet publication].全文

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • 鉴别诊断

    • Infectious mononucleosis
    • Toxoplasmosis
    • Viral hepatitis
    更多 鉴别诊断
  • Guidelines

    • Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States
    • Care of pregnant women living with HIV and interventions to reduce perinatal transmission
    更多 Guidelines
  • Patient information

    HIV infection in pregnancy

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer